Literature DB >> 31415337

Comparative Responsiveness and Minimally Important Difference of Common Anxiety Measures.

Kurt Kroenke1,2,3, Fitsum Baye4, Spencer G Lourens4.   

Abstract

BACKGROUND: Anxiety is one of the most prevalent mental disorders and accounts for substantial disability as well as increased health care costs. This study examines the minimally important difference (MID) and responsiveness of 6 commonly used anxiety scales.
METHODS: The sample comprised 294 patients from 6 primary care clinics in a single VA medical center who were enrolled in a telecare trial for treatment of chronic musculoskeletal pain and comorbid depression and/or anxiety. The measures assessed were the Patient Reported Outcomes Measurement Information System (PROMIS) 4-item, 6-item, and 8-item anxiety scales; the Generalized Anxiety Disorder 7-item scale (GAD-7); the Symptom Checklist anxiety subscale (SCL); the Posttraumatic Stress Disorder Checklist (PCL); the Short Form (SF)-36 Mental Health subscale; and the SF-12 Mental Component Summary (MCS). Validity was assessed with correlations of these measures with one another and with measures of quality of life and disability. MID was estimated by triangulating several methods. Responsiveness was evaluated by comparing: (a) the standardized response means for patients who reported their mood as being better, the same, or worse at 3 months; (b) the area under the curve for patients who had improved (better) versus those who had not (same/worse).
RESULTS: Convergent and construct validity was supported by strong correlations of the anxiety measures with one another and moderate correlations with quality of life and disability measures, respectively. All measures differentiated patients who reported global improvement at 3 months from those who were unchanged, but were less able to distinguish worsening from no change. The area under the curves showed comparable responsiveness of the scales. The estimated MID was 4 for the PROMIS scales; 3 for the GAD-7; 6 for the PCL; 9 for the SF-36 mental health subscale; 5 for the MCS score, and 0.3 for the SCL anxiety scale.
CONCLUSIONS: Six commonly used anxiety scales demonstrate similar responsiveness, and estimated MIDs can be used to gauge anxiety change in clinical research and practice.

Entities:  

Mesh:

Year:  2019        PMID: 31415337     DOI: 10.1097/MLR.0000000000001185

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  15 in total

1.  Depression and Anxiety Screening Identifies Patients That may Benefit From Treatment Regardless of Existing Diagnoses.

Authors:  Brandon Lippold; Yash R Tarkunde; Abby L Cheng; Charles P Hannon; Muyibat A Adelani; Ryan P Calfee
Journal:  Arthroplast Today       Date:  2022-03-02

2.  A Randomized Preference Trial Comparing Cognitive-Behavioral Therapy and Yoga for the Treatment of Late-Life Worry: Examination of Impact on Depression, Generalized Anxiety, Fatigue, Pain, Social Participation, and Physical Function.

Authors:  Suzanne C Danhauer; Michael E Miller; Jasmin Divers; Andrea Anderson; Gena Hargis; Gretchen A Brenes
Journal:  Glob Adv Health Med       Date:  2022-05-16

3.  Reliability, Validity, and Responsiveness of the DEG, a Three-Item Dyspnea Measure.

Authors:  Duc M Ha; Lubin R Deng; Allison V Lange; Jeffrey J Swigris; David B Bekelman
Journal:  J Gen Intern Med       Date:  2022-01-03       Impact factor: 6.473

4.  A Pilot Study on Playback Theatre as a Therapeutic Aid after Natural Disasters: Brain Connectivity Mechanisms of Effects on Anxiety.

Authors:  Sarat Munjuluri; Peter K Bolin; Y T Amy Lin; Nina L Garcia; Leslie Gauna; Tien Nguyen; Ramiro Salas
Journal:  Chronic Stress (Thousand Oaks)       Date:  2020-11-03

5.  Assessment of Financial Toxicity Among Older Adults With Advanced Cancer.

Authors:  Asad Arastu; Arpan Patel; Supriya Gupta Mohile; Joseph Ciminelli; Ramya Kaushik; Megan Wells; Eva Culakova; Lianlian Lei; Huiwen Xu; David W Dougherty; Mostafa R Mohamed; Elaine Hill; Paul Duberstein; Marie Anne Flannery; Charles Stewart Kamen; Chintan Pandya; Jeffrey L Berenberg; Valerie G Aarne Grossman; Yang Liu; Kah Poh Loh
Journal:  JAMA Netw Open       Date:  2020-12-01

6.  Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.

Authors:  Brett D Thombs; Linda Kwakkenbos; Marie-Eve Carrier; Angelica Bourgeault; Lydia Tao; Sami Harb; Maria Gagarine; Danielle Rice; Laura Bustamante; Kelsey Ellis; Delaney Duchek; Yin Wu; Parash Mani Bhandari; Dipika Neupane; Andrea Carboni-Jiménez; Richard S Henry; Ankur Krishnan; Ying Sun; Brooke Levis; Chen He; Kimberly A Turner; Andrea Benedetti; Nicole Culos-Reed; Ghassan El-Baalbaki; Shannon Hebblethwaite; Susan J Bartlett; Laura Dyas; Scott Patten; John Varga
Journal:  J Psychosom Res       Date:  2020-05-14       Impact factor: 3.006

7.  Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

Authors:  Brett D Thombs; Linda Kwakkenbos; Richard S Henry; Marie-Eve Carrier; Scott Patten; Sami Harb; Angelica Bourgeault; Lydia Tao; Susan J Bartlett; Luc Mouthon; John Varga; Andrea Benedetti
Journal:  J Psychosom Res       Date:  2020-10-03       Impact factor: 3.006

8.  Responsiveness of PROMIS and Patient Health Questionnaire (PHQ) Depression Scales in three clinical trials.

Authors:  Kurt Kroenke; Timothy E Stump; Chen X Chen; Jacob Kean; Teresa M Damush; Matthew J Bair; Erin E Krebs; Patrick O Monahan
Journal:  Health Qual Life Outcomes       Date:  2021-02-04       Impact factor: 3.186

9.  Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Matthew W Roché; Rebecca E Ready; Joel S Perlmutter; Kelvin L Chou; Stacey K Barton; Michael K McCormack; Julie C Stout; David Cella; Jennifer A Miner; Jane S Paulsen
Journal:  Qual Life Res       Date:  2020-08-19       Impact factor: 4.147

10.  Validation of PROMIS-29 domain scores among adult burn survivors: A National Institute on Disability, Independent Living, and Rehabilitation Research Burn Model System Study.

Authors:  Kara McMullen; Alyssa Bamer; Colleen M Ryan; Jeffrey C Schneider; Nicole Gibran; Barclay T Stewart; Tracy Mroz; Steven Wolf; Dagmar Amtmann
Journal:  J Trauma Acute Care Surg       Date:  2022-01-01       Impact factor: 3.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.